| Year |
Citation |
Score |
| 2024 |
Simmons SC, Flerlage WJ, Langlois LD, Shepard RD, Bouslog C, Thomas EH, Gouty KM, Sanderson JL, Gouty S, Cox BM, Dell'Acqua ML, Nugent FS. AKAP150-anchored PKA regulates synaptic transmission and plasticity, neuronal excitability and CRF neuromodulation in the mouse lateral habenula. Communications Biology. 7: 345. PMID 38509283 DOI: 10.1038/s42003-024-06041-8 |
0.66 |
|
| 2023 |
Simmons SC, Flerlage WJ, Langlois LD, Shepard RD, Bouslog C, Thomas EH, Gouty KM, Sanderson JL, Gouty S, Cox BM, Dell'Acqua ML, Nugent FS. AKAP150-anchored PKA regulation of synaptic transmission and plasticity, neuronal excitability and CRF neuromodulation in the lateral habenula. Biorxiv : the Preprint Server For Biology. PMID 38106086 DOI: 10.1101/2023.12.06.570160 |
0.657 |
|
| 2022 |
Flerlage WJ, Langlois LD, Rusnak M, Simmons SC, Gouty S, Armstrong RC, Cox BM, Symes A, Tsuda MC, Nugent F. Involvement of Lateral Habenula Dysfunction in Repetitive Mild Traumatic Brain Injury-Induced Motivational Deficits. Journal of Neurotrauma. PMID 35972745 DOI: 10.1089/neu.2022.0224 |
0.645 |
|
| 2020 |
Simmons SC, Shepard RD, Gouty S, Langlois LD, Flerlage WJ, Cox BM, Nugent FS. Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula. Neurobiology of Stress. 13: 100267. PMID 33344720 DOI: 10.1016/j.ynstr.2020.100267 |
0.672 |
|
| 2020 |
Gomes I, Sierra S, Lueptow L, Gupta A, Gouty S, Margolis EB, Cox BM, Devi LA. Biased signaling by endogenous opioid peptides. Proceedings of the National Academy of Sciences of the United States of America. PMID 32393639 DOI: 10.1073/Pnas.2000712117 |
0.411 |
|
| 2020 |
Cox BM. A concise review of concepts in opioid pharmacology up to the discovery of endogenous opioids. Molecular Pharmacology. PMID 32234811 DOI: 10.1124/Mol.120.119420 |
0.375 |
|
| 2019 |
Borsodi A, Bruchas M, Caló G, Chavkin C, Christie MJ, Civelli O, Connor M, Cox BM, Devi LA, Evans C, Höllt V, Henderson G, Husbands S, Kelly E, Kieffer B, et al. Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f50/2019.4 |
0.56 |
|
| 2018 |
Shepard RD, Gouty S, Kassis H, Berenji A, Zhu W, Cox BM, Nugent FS. Targeting histone deacetylation for recovery of maternal deprivation-induced changes in BDNF and AKAP150 expression in the VTA. Experimental Neurology. PMID 30102916 DOI: 10.1016/J.Expneurol.2018.08.002 |
0.685 |
|
| 2016 |
Authement ME, Langlois LD, Kassis H, Gouty S, Dacher M, Shepard RD, Cox BM, Nugent FS. Morphine-induced synaptic plasticity in the VTA is reversed by HDAC inhibition. Journal of Neurophysiology. jn.00238.2016. PMID 27306674 DOI: 10.1152/Jn.00238.2016 |
0.702 |
|
| 2015 |
Santhappan R, Crowder AT, Gouty S, Cox BM, Côté TE. Mu Opioid Receptor Activation Enhances Regulator of G protein Signaling 4 Association with the Mu Opioid Receptor/G protein Complex in a GTP-Dependent Manner. Journal of Neurochemistry. PMID 26119705 DOI: 10.1111/Jnc.13222 |
0.376 |
|
| 2015 |
Authement ME, Kodangattil JN, Gouty S, Rusnak M, Symes AJ, Cox BM, Nugent FS. Histone Deacetylase Inhibition Rescues Maternal Deprivation-Induced GABAergic Metaplasticity through Restoration of AKAP Signaling. Neuron. 86: 1240-52. PMID 26050042 DOI: 10.1016/J.Neuron.2015.05.024 |
0.684 |
|
| 2015 |
Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. Challenges for opioid receptor nomenclature: IUPHAR Review 9. British Journal of Pharmacology. 172: 317-23. PMID 24528283 DOI: 10.1111/Bph.12612 |
0.361 |
|
| 2013 |
Dacher M, Gouty S, Dash S, Cox BM, Nugent FS. A-kinase anchoring protein-calcineurin signaling in long-term depression of GABAergic synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 2650-60. PMID 23392692 DOI: 10.1523/Jneurosci.2037-12.2013 |
0.684 |
|
| 2013 |
Cox B, Han JS, Dingledine R. Avram Goldstein: the founder of molecular pharmacology. Molecular Pharmacology. 83: 720-2. PMID 23329728 DOI: 10.1124/Mol.112.084640 |
0.483 |
|
| 2013 |
Cox BM. Recent developments in the study of opioid receptors. Molecular Pharmacology. 83: 723-8. PMID 23249538 DOI: 10.1124/Mol.112.083279 |
0.355 |
|
| 2010 |
Gouty S, Brown JM, Rosenberger J, Cox BM. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons. Neuroscience. 169: 269-78. PMID 20417255 DOI: 10.1016/J.Neuroscience.2010.04.033 |
0.321 |
|
| 2009 |
Di Benedetto M, Cavina C, D'Addario C, Leoni G, Candeletti S, Cox BM, Romualdi P. Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats. Neuropharmacology. 56: 761-7. PMID 19162046 DOI: 10.1016/J.Neuropharm.2008.12.009 |
0.342 |
|
| 2006 |
Brown JM, Gouty S, Iyer V, Rosenberger J, Cox BM. Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. Journal of Neurochemistry. 98: 495-505. PMID 16749908 DOI: 10.1111/J.1471-4159.2006.03902.X |
0.308 |
|
| 2005 |
Marti M, Mela F, Fantin M, Zucchini S, Brown JM, Witta J, Di Benedetto M, Buzas B, Reinscheid RK, Salvadori S, Guerrini R, Romualdi P, Candeletti S, Simonato M, Cox BM, et al. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9591-601. PMID 16237164 DOI: 10.1523/Jneurosci.2546-05.2005 |
0.367 |
|
| 2005 |
Cox BM. Agonists at mu-opioid receptors spin the wheels to keep the action going. Molecular Pharmacology. 67: 12-4. PMID 15496509 DOI: 10.1124/Mol.104.008433 |
0.372 |
|
| 2004 |
Cox BM, Crowder AT. Receptor domains regulating mu opioid receptor uncoupling and internalization: relevance to opioid tolerance. Molecular Pharmacology. 65: 492-5. PMID 14978226 DOI: 10.1124/Mol.65.3.492 |
0.369 |
|
| 2004 |
Witta J, Palkovits M, Rosenberger J, Cox BM. Distribution of nociceptin/orphanin FQ in adult human brain. Brain Research. 997: 24-9. PMID 14715146 DOI: 10.1016/J.Brainres.2003.08.066 |
0.32 |
|
| 2003 |
Witta J, Buzas B, Cox BM. Traumatic brain injury induces nociceptin/orphanin FQ expression in neurons of the rat cerebral cortex. Journal of Neurotrauma. 20: 523-32. PMID 12906737 DOI: 10.1089/089771503767168456 |
0.305 |
|
| 2001 |
Romualdi P, D'Addario C, Ferri S, Cox BM, Izenwasser S. Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine. European Journal of Pharmacology. 413: 207-12. PMID 11226394 DOI: 10.1016/S0014-2999(01)00776-2 |
0.613 |
|
| 2000 |
Chalecka-Franaszek E, Weems HB, Crowder AT, Cox BM, Côté TE. Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized mu-opioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3). Journal of Neurochemistry. 74: 1068-78. PMID 10693938 DOI: 10.1046/J.1471-4159.2000.0741068.X |
0.307 |
|
| 1999 |
Buzas B, Symes AJ, Cox BM. Regulation of nociceptin/orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes. Journal of Neurochemistry. 72: 1882-9. PMID 10217264 DOI: 10.1046/J.1471-4159.1999.0721882.X |
0.315 |
|
| 1998 |
Winkler A, Búzás B, Siems WE, Heder G, Cox BM. Effect of ethanol drinking on the gene expression of opioid receptors, enkephalinase, and angiotensin-converting enzyme in two inbred mice strains. Alcoholism, Clinical and Experimental Research. 22: 1262-71. PMID 9756041 DOI: 10.1111/J.1530-0277.1998.Tb03907.X |
0.312 |
|
| 1998 |
Azaryan AV, Clock BJ, Rosenberger JG, Cox BM. Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Canadian Journal of Physiology and Pharmacology. 76: 278-83. PMID 9673791 DOI: 10.1139/Y98-023 |
0.387 |
|
| 1998 |
Buzas B, Rosenberger J, Cox BM. Ca2+/calmodulin-dependent transcriptional activation of delta-opioid receptor gene expression induced by membrane depolarization in NG108-15 cells. Journal of Neurochemistry. 70: 105-12. PMID 9422352 DOI: 10.1046/J.1471-4159.1998.70010105.X |
0.316 |
|
| 1997 |
Búzás B, Cox BM. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience. 76: 479-89. PMID 9015332 DOI: 10.1016/S0306-4522(96)00242-4 |
0.367 |
|
| 1997 |
Buzas B, Rosenberger J, Cox BM. Regulation of delta-opioid receptor mRNA levels by receptor-mediated and direct activation of the adenylyl cyclase-protein kinase A pathway. Journal of Neurochemistry. 68: 610-5. PMID 9003047 DOI: 10.1046/J.1471-4159.1997.68020610.X |
0.374 |
|
| 1996 |
Buzas B, Rosenberger J, Cox BM. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport. 7: 1505-8. PMID 8856708 DOI: 10.1097/00001756-199606170-00013 |
0.406 |
|
| 1996 |
Izenwasser S, Heller B, Cox BM. Continuous cocaine administration enhances mu- but not delta-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens. European Journal of Pharmacology. 297: 187-91. PMID 8851182 DOI: 10.1016/0014-2999(95)00828-4 |
0.657 |
|
| 1996 |
Izenwasser S, Newman AH, Cox BM, Katz JL. The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter. European Journal of Pharmacology. 297: 9-17. PMID 8851160 DOI: 10.1016/0014-2999(95)00696-6 |
0.647 |
|
| 1996 |
Romualdi P, Donatini A, Izenwasser S, Cox BM, Ferri S. Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen. Brain Research. Molecular Brain Research. 40: 153-6. PMID 8840025 DOI: 10.1016/0169-328X(96)00091-5 |
0.623 |
|
| 1996 |
Noble F, Cox BM. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. British Journal of Pharmacology. 117: 161-9. PMID 8825358 DOI: 10.1111/J.1476-5381.1996.Tb15169.X |
0.424 |
|
| 1996 |
Tang T, Stevens BA, Cox BM. Opioid regulation of intracellular free calcium in cultured mouse dorsal root ganglion neurons. Journal of Neuroscience Research. 44: 338-43. PMID 8739152 DOI: 10.1002/(Sici)1097-4547(19960515)44:4<338::Aid-Jnr4>3.0.Co;2-D |
0.347 |
|
| 1996 |
Noble F, Cox BM. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors. Brain Research. 716: 107-17. PMID 8738226 DOI: 10.1016/0006-8993(96)00005-4 |
0.385 |
|
| 1996 |
Azaryan AV, Coughlin LJ, Búzás B, Clock BJ, Cox BM. Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions. Journal of Neurochemistry. 66: 443-8. PMID 8592112 DOI: 10.1046/J.1471-4159.1996.66020443.X |
0.401 |
|
| 1995 |
Noble F, Cox BM. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. Journal of Neurochemistry. 65: 125-33. PMID 7790855 DOI: 10.1046/J.1471-4159.1995.65010125.X |
0.412 |
|
| 1995 |
Tang T, Kiang JG, Cote T, Cox BM. Opioid-induced increase in [Ca2+]i in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells is mediated through G protein-coupled delta-opioid receptors and desensitized by chronic exposure to opioid. Journal of Neurochemistry. 65: 1612-21. PMID 7561856 DOI: 10.1046/J.1471-4159.1995.65041612.X |
0.342 |
|
| 1994 |
Búzás B, Izenwasser S, Portoghese PS, Cox BM. Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Life Sciences. 54: PL101-6. PMID 8309345 DOI: 10.1016/0024-3205(94)00412-9 |
0.624 |
|
| 1994 |
Búzás B, Cox BM. Competitive PCR assay for quantitation of mu and delta opioid receptor messenger-RNA levels in small tissue samples Regulatory Peptides. 54: 35-36. DOI: 10.1016/0167-0115(94)90376-X |
0.326 |
|
| 1993 |
Izenwasser S, Rosenberger JG, Cox BM. The cocaine analog WIN 35,428 binds to two sites in fresh rat caudate-putamen: significance of assay procedures. Life Sciences. 52: PL141-5. PMID 8464332 DOI: 10.1016/0024-3205(93)90179-7 |
0.582 |
|
| 1993 |
Unterwald EM, Cox BM, Kreek MJ, Cote TE, Izenwasser S. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse (New York, N.Y.). 15: 33-8. PMID 8310423 DOI: 10.1002/Syn.890150104 |
0.65 |
|
| 1993 |
Izenwasser S, Búzás B, Cox BM. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. The Journal of Pharmacology and Experimental Therapeutics. 267: 145-52. PMID 7901389 |
0.611 |
|
| 1993 |
Izenwasser S, Unterwald EM, Cote TE, Cox BM, Kreek MJ. Repeated, daily cocaine administration produces changes in basal and opioid-regulated adenylyl cyclase activity in rat caudate-putamen and nucleus accubens Nida Research Monograph Series. 392. |
0.605 |
|
| 1992 |
Izenwasser S, Rosenberger JG, Cox BM. Inhibition of [3H]dopamine and [3H]serotonin uptake by cocaine: comparison between chopped tissue slices and synaptosomes. Life Sciences. 50: 541-7. PMID 1736024 DOI: 10.1016/0024-3205(92)90365-V |
0.607 |
|
| 1992 |
Izenwasser S, Cox BM. Inhibition of dopamine uptake by cocaine and nicotine: tolerance to chronic treatments. Brain Research. 573: 119-25. PMID 1576529 DOI: 10.1016/0006-8993(92)90120-X |
0.605 |
|
| 1991 |
Izenwasser S, Jacocks HM, Rosenberger JG, Cox BM. Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatum. Journal of Neurochemistry. 56: 603-10. PMID 1988558 DOI: 10.1111/J.1471-4159.1991.Tb08192.X |
0.588 |
|
| 1991 |
Jacocks HM, Izenwasser S, Werling LL, Cox BM. Comparison of dopamine uptake and release in vitro in sheep and rat striatum. Life Sciences. 49: 481-8. PMID 1830633 DOI: 10.1016/0024-3205(91)90064-I |
0.605 |
|
| 1990 |
Izenwasser S, Cox BM. Daily cocaine treatment produces a persistent reduction of [3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Research. 531: 338-41. PMID 2289133 DOI: 10.1016/0006-8993(90)90797-F |
0.614 |
|
| 1990 |
Izenwasser S, Werling LL, Cox BM. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Research. 520: 303-9. PMID 2145054 DOI: 10.1016/0006-8993(90)91719-W |
0.603 |
|
| 1990 |
Izenwasser S, Werling LL, Rosenberger JG, Cox BM. Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways. Neuropharmacology. 29: 1017-24. PMID 2087254 DOI: 10.1016/0028-3908(90)90107-3 |
0.596 |
|
| 1990 |
Izenwasser S, Jacocks HM, Cox BM. Effect of (-) and (+) nicotine of [3H]DA uptake and release in rat striatum. Nida Research Monograph. 105: 330. PMID 1678868 |
0.54 |
|
| 1990 |
Werling LL, McMahon PN, Cox BM. A comparison of kappa opioid-, sigma-, and phencyclidine (PCP)-receptor regulation of dopamine release from striatal slices European Journal of Pharmacology. 183: 982-983. DOI: 10.1016/0014-2999(90)92826-5 |
0.398 |
|
| 1989 |
Romualdi P, Rosenberger JG, Gozzini L, Cox BM. Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat. Peptides. 10: 621-6. PMID 2780421 DOI: 10.1016/0196-9781(89)90153-8 |
0.334 |
|
| 1989 |
Izenwasser S, Werling LL, Cox BM. Binding of [3H]GBR 12935 in the striatum, medial prefrontal cortex, nucleus accumbens and olfactory tubercle of rat. Nida Research Monograph. 95: 341-2. PMID 2640988 |
0.537 |
|
| 1989 |
Puttfarcken PS, Cox BM. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sciences. 45: 1937-42. PMID 2557508 DOI: 10.1016/0024-3205(89)90548-1 |
0.399 |
|
| 1989 |
Werling LL, McMahon PN, Cox BM. Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices. Naunyn-Schmiedeberg's Archives of Pharmacology. 339: 509-13. PMID 2549429 DOI: 10.1007/Bf00167253 |
0.438 |
|
| 1989 |
Werling LL, McMahon PN, Cox BM. Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Proceedings of the National Academy of Sciences of the United States of America. 86: 6393-7. PMID 2548212 DOI: 10.1073/Pnas.86.16.6393 |
0.397 |
|
| 1989 |
Werling LL, McMahon PN, Portoghese PS, Takemori AE, Cox BM. Selective opioid antagonist effects on opioid-induced inhibition of release of norepinephrine in guinea pig cortex. Neuropharmacology. 28: 103-7. PMID 2541364 DOI: 10.1016/0028-3908(89)90044-0 |
0.409 |
|
| 1988 |
Werling LL, McMahon PN, Cox BM. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex. The Journal of Pharmacology and Experimental Therapeutics. 247: 1103-6. PMID 2849659 |
0.311 |
|
| 1988 |
Romualdi P, Cox BM, Ferri S. Evidence for the presence of VIP 22-28 heptapeptide in rat brain cortex Pharmacological Research Communications. 20: 35-36. DOI: 10.1016/S0031-6989(88)80628-3 |
0.3 |
|
| 1987 |
Cox BM, Rosenberger JG, Douglass J. Chromatographic characterization of dynorphin and [Leu5]enkephalin immunoreactivity in guinea pig and rat testis. Regulatory Peptides. 19: 1-12. PMID 2891155 DOI: 10.1016/0167-0115(87)90069-3 |
0.356 |
|
| 1987 |
Douglass J, Cox B, Quinn B, Civelli O, Herbert E. Expression of the prodynorphin gene in male and female mammalian reproductive tissues. Endocrinology. 120: 707-13. PMID 2879723 DOI: 10.1210/Endo-120-2-707 |
0.364 |
|
| 1987 |
Werling LL, Brown SR, Cox BM. Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology. 26: 987-96. PMID 2821438 DOI: 10.1016/0028-3908(87)90077-3 |
0.429 |
|
| 1986 |
Cox BM, Chavkin C. Properties of receptors mediating opioid effects: discrimination of receptor types. Nida Research Monograph. 71: 1-18. PMID 3025728 |
0.535 |
|
| 1986 |
Zarr GD, Werling LL, Brown SR, Cox BM. Opioid ligand binding sites in the spinal cord of the guinea-pig. Neuropharmacology. 25: 471-80. PMID 3016586 DOI: 10.1016/0028-3908(86)90170-X |
0.314 |
|
| 1984 |
Cox BM, Goldstein A, Nelson WT. Nicotine self-administration in rats. British Journal of Pharmacology. 83: 49-55. PMID 6487896 DOI: 10.1111/J.1476-5381.1984.Tb10118.X |
0.538 |
|
| 1984 |
Molineaux CJ, Rosenberger JG, Cox BM. Subcellular distribution of opioid peptides in rat hypothalamus and pituitary. Journal of Neurochemistry. 43: 1616-23. PMID 6149267 DOI: 10.1111/J.1471-4159.1984.Tb06086.X |
0.338 |
|
| 1984 |
Werling LL, Brown S, Cox BM. The sensitivity of opioid receptor types to regulation by sodium and GTP. Neuropeptides. 5: 137-40. PMID 6099482 DOI: 10.1016/0143-4179(84)90046-5 |
0.341 |
|
| 1983 |
Whitnall MH, Gainer H, Cox BM, Molineaux CJ. Dynorphin-A-(1-8) is contained within vasopressin neurosecretory vesicles in rat pituitary. Science (New York, N.Y.). 222: 1137-9. PMID 6648526 DOI: 10.1126/Science.6648526 |
0.371 |
|
| 1983 |
Feuerstein G, Molineaux CJ, Rosenberger JG, Faden AI, Cox BM. Dynorphins and Leu-enkephalin in brain nuclei and pituitary of WKY and SHR rats. Peptides. 4: 225-9. PMID 6622288 DOI: 10.1016/0196-9781(83)90119-5 |
0.341 |
|
| 1983 |
Cox BM, Chavkin C. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency. Molecular Pharmacology. 23: 36-43. PMID 6135144 |
0.509 |
|
| 1982 |
Cox BM. Opioids at Cape Cod. Nature. 298: 790-1. PMID 6287273 DOI: 10.1038/298790A0 |
0.34 |
|
| 1982 |
Molineaux CJ, Feuerstein G, Faden AL, Cox BM. Distribution of immunoreactive dynorphin in discrete brain nuclei; comparison with vasopressin. Neuroscience Letters. 33: 179-84. PMID 6130498 DOI: 10.1016/0304-3940(82)90248-8 |
0.321 |
|
| 1982 |
Cox BM. Endogenous opioid peptides: a guide to structures and terminology. Life Sciences. 31: 1645-58. PMID 6130429 DOI: 10.1016/0024-3205(82)90179-5 |
0.36 |
|
| 1981 |
Dent RR, Guilleminault C, Albert LH, Posner BI, Cox BM, Goldstein A. Diurnal rhythm of plasma immunoreactive beta-endorphin and its relationship to sleep stages and plasma rhythms of cortisol and prolactin. The Journal of Clinical Endocrinology and Metabolism. 52: 942-7. PMID 6262357 DOI: 10.1210/Jcem-52-5-942 |
0.512 |
|
| 1981 |
Botticelli LJ, Cox BM, Goldstein A. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences of the United States of America. 78: 7783-6. PMID 6121324 |
0.463 |
|
| 1980 |
Cox BM, Leslie FM, Chavkin C. Characteristics of peptide and alkaloid opiate binding sites in brain and peripheral tissues. Advances in Biochemical Psychopharmacology. 22: 353-62. PMID 6249080 |
0.497 |
|
| 1980 |
Leslie FM, Chavkin C, Cox BM. Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites. The Journal of Pharmacology and Experimental Therapeutics. 214: 395-402. PMID 6248635 |
0.525 |
|
| 1980 |
Ghazarossian VE, Dent RR, Otsu K, Ross M, Cox B, Goldstein A. Development and validation of a sensitive radioimmunoassay for naturally occurring beta-endorphin-like peptides in human plasma. Analytical Biochemistry. 102: 80-9. PMID 6153517 DOI: 10.1016/0003-2697(80)90321-8 |
0.523 |
|
| 1980 |
Cox BM, Ghazarossian VE, Goldstein A. Levels of immunoreactive dynorphin in brain and pituitary of Brattleboro rats. Neuroscience Letters. 20: 85-8. PMID 6133255 DOI: 10.1016/0304-3940(80)90238-4 |
0.609 |
|
| 1980 |
Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1–13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152. DOI: 10.1016/0143-4179(80)90017-7 |
0.554 |
|
| 1980 |
Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1-13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152. |
0.648 |
|
| 1979 |
Baizman ER, Cox BM, Osman OH, Goldstein A. Experimental alterations of endorphin levels in rat pituitary. Neuroendocrinology. 28: 402-14. PMID 572491 |
0.534 |
|
| 1979 |
Chavkin C, Cox BM, Goldstein A. Stereospecific opiate binding in bovine adrenal medulla. Molecular Pharmacology. 15: 751-3. PMID 226864 |
0.47 |
|
| 1979 |
Cox BM, Ross M, Goldstein A, Palmour RM. Pharmacological and immunological characterization of the Leu5 analogue of human beta-endorphin. Brain Research. 165: 311-9. PMID 217494 DOI: 10.1016/0006-8993(79)90562-6 |
0.542 |
|
| 1978 |
Gentleman S, Lowney LI, Cox BM, Goldstein A. Rapid purification of beta-endorphin by high-performance liquid chromatography. Journal of Chromatography. 153: 274-8. PMID 659560 DOI: 10.1016/S0021-9673(00)89885-4 |
0.499 |
|
| 1978 |
Ross M, Ghazarossian V, Cox BM, Goldstein A. Radioimmunoassays for beta-endorphin: comparison of properties of two antisera. Life Sciences. 22: 1123-30. PMID 566365 DOI: 10.1016/0024-3205(78)90081-4 |
0.567 |
|
| 1977 |
Goldstein A, Cox BM. Opioid peptides (endorphins) in pituitary and brain. Psychoneuroendocrinology. 2: 11-6. PMID 905473 DOI: 10.1016/0306-4530(77)90027-0 |
0.589 |
|
| 1977 |
Ross M, Dingledine R, Cox BM, Goldstein A. Distribution of endorphins (peptides with morphine-like pharmacological activity) in pituitary. Brain Research. 124: 523-32. PMID 851863 DOI: 10.1016/0006-8993(77)90951-9 |
0.675 |
|
| 1977 |
Goldstein A, Cox BM, Klee WA, Nirenberg M. Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells. Nature. 265: 362-3. PMID 189215 DOI: 10.1038/265362A0 |
0.574 |
|
| 1977 |
Goldstein A, Cox BM, Gentleman S, Lowney LI, Cheung AL. PITUITARY AND BRAIN OPIOID PEPTIDES (ENDORPHINS) Annals of the New York Academy of Sciences. 297: 108-114. DOI: 10.1111/J.1749-6632.1977.Tb41848.X |
0.602 |
|
| 1976 |
Cox BM, Goldstein A, Hi CH. Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proceedings of the National Academy of Sciences of the United States of America. 73: 1821-3. PMID 1064855 |
0.542 |
|
| 1976 |
Cox BM, Gentleman S, Su TP, Goldstein A. Further characterization of morphine-like peptides (endorphins) from pituitary. Brain Research. 115: 285-96. PMID 10049 DOI: 10.1016/0006-8993(76)90513-8 |
0.599 |
|
| 1975 |
Goldstein A, Goldstein JS, Cox BM. A synthetic peptide with morphine-like pharmacologic action. Life Sciences. 17: 1643-54. PMID 1207378 DOI: 10.1016/0024-3205(75)90109-5 |
0.605 |
|
| 1975 |
Teschemacher H, Opheim KE, Cox BM, Goldstein A. A peptide-like substance from pituitary that acts like morphine. I. Isolation. Life Sciences. 16: 1771-5. PMID 1171343 |
0.537 |
|
| 1975 |
Cox BM, Ginsburg M, Willis J. The offset of morphine tolerance in rats and mice. British Journal of Pharmacology. 53: 383-91. PMID 1169082 DOI: 10.1111/J.1476-5381.1975.Tb07374.X |
0.339 |
|
| 1975 |
Cox BM, Opheim KE, Teschemacher H, Goldstein A. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sciences. 16: 1777-82. PMID 1152601 DOI: 10.1016/0024-3205(75)90272-6 |
0.627 |
|
| 1970 |
Cox BM, Osman OH. Inhibition of the development of tolerance to morphine in rats by drugs which inhibit ribonucleic acid or protein synthesis. British Journal of Pharmacology. 38: 157-70. PMID 5413284 DOI: 10.1111/J.1476-5381.1970.Tb10344.X |
0.331 |
|
| Show low-probability matches. |
